The search for a convenient procedure to detect one of the earliest signs of Alzheimer's disease: A systematic review of the prediction of brain amyloid status

Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer’s Disease Multimodal Biomarker Discovery Cohort

(2020) Sarah Westwood et al.   JOURNAL OF ALZHEIMERS DISEASE

Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts

(2020) Thomas K Karikari et al.   LANCET NEUROLOGY

Elecsys CSF biomarker immunoassays demonstrate concordance with amyloid-PET imaging

(2020) James D. Doecke et al.   Alzheimers Research & Therapy

Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders

(2020) Sebastian Palmqvist et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer’s disease

(2020) Nicolas R. Barthélemy et al.   JOURNAL OF EXPERIMENTAL MEDICINE

PROBAST: A Tool to Assess Risk of Bias and Applicability of Prediction Model Studies: Explanation and Elaboration

(2019) Karel G.M. Moons et al.   ANNALS OF INTERNAL MEDICINE

PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies

(2019) Robert F. Wolff et al.   ANNALS OF INTERNAL MEDICINE

A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer’s disease

(2019) Nicholas J. Ashton et al.   Science Advances

Centiloid cut-off values for optimal agreement between PET and CSF core AD biomarkers

(2019) Gemma Salvadó et al.   Alzheimers Research & Therapy

Reduction of recruitment costs in preclinical AD trials: validation of automatic pre-screening algorithm for brain amyloidosis

(2019) Manon Ansart et al.   STATISTICAL METHODS IN MEDICAL RESEARCH

GeneMatch: A novel recruitment registry using at-home APOE genotyping to enhance referrals to Alzheimer's prevention studies

(2019) Jessica B. Langbaum et al.   Alzheimers & Dementia

Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease

(2019) Andrea Vergallo et al.   Alzheimers & Dementia

Cognitive Profiling Related to Cerebral Amyloid Beta Burden Using Machine Learning Approaches

(2019) Hyunwoong Ko et al.   Frontiers in Aging Neuroscience

Genetic risk for Alzheimer's disease is distinct from genetic risk for amyloid deposition

(2019) Ganna Leonenko et al.   ANNALS OF NEUROLOGY

Abnormal platelet amyloid‐β precursor protein metabolism in SAMP8 mice: Evidence for peripheral marker in Alzheimer's disease

(2019) Lizhi Chen et al.   JOURNAL OF CELLULAR PHYSIOLOGY

β-amyloid pathology and hippocampal atrophy are independently associated with memory function in cognitively healthy elderly

(2019) Anna L. Svenningsson et al.   Scientific Reports

Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease–Related β-Amyloid Status

(2019) Sebastian Palmqvist et al.   JAMA Neurology

Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay

(2019) Liu Shi et al.   Alzheimers & Dementia

Prediction of amyloid pathology in cognitively unimpaired individuals using voxel-wise analysis of longitudinal structural brain MRI

(2019) Paula M. Petrone et al.   Alzheimers Research & Therapy

Multi-omics signature of brain amyloid deposition in asymptomatic individuals at-risk for Alzheimer's disease: The INSIGHT-preAD study

(2019) Laura Xicota et al.   EBioMedicine

Ultrasensitive Detection of Plasma Amyloid-β as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer’s Disease

(2019) Pratishtha Chatterjee et al.   JOURNAL OF ALZHEIMERS DISEASE

Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer’s disease

(2019) Xavier Hadoux et al.   Nature Communications

Prognostic models for outcome prediction in patients with chronic obstructive pulmonary disease: systematic review and critical appraisal

(2019) Vanesa Bellou et al.   BMJ-British Medical Journal

Predicting Amyloid-β Levels in Amnestic Mild Cognitive Impairment Using Machine Learning Techniques

(2019) Ali Ezzati et al.   JOURNAL OF ALZHEIMERS DISEASE

Prognostic plasma protein panel for Aβ deposition in the brain in Alzheimer’s disease

(2019) Jong-Chan Park et al.   PROGRESS IN NEUROBIOLOGY

Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study

(2019) Virginia Pérez-Grijalba et al.   Alzheimers Research & Therapy

Plasma amyloid assay as a pre-screening tool for amyloid positron emission tomography imaging in early stage Alzheimer’s disease

(2019) Szu-Ying Lin et al.   Alzheimers Research & Therapy

Forecasting the prevalence of preclinical and clinical Alzheimer's disease in the United States

(2018) Ron Brookmeyer et al.   Alzheimers & Dementia

The Brain Health Registry: An internet-based platform for recruitment, assessment, and longitudinal monitoring of participants for neuroscience studies

(2018) Michael W. Weiner et al.   Alzheimers & Dementia

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

(2018) Clifford R. Jack et al.   Alzheimers & Dementia

Effects of amyloid pathology and neurodegeneration on cognitive change in cognitively normal adults

(2018) Murat Bilgel et al.   BRAIN

Amyloid Accumulation and Cognitive Decline in Clinically Normal Older Individuals: Implications for Aging and Early Alzheimer’s Disease

(2018) Elizabeth C. Mormino et al.   JOURNAL OF ALZHEIMERS DISEASE

Constructing a Local Potential Participant Registry to Improve Alzheimer’s Disease Clinical Research Recruitment

(2018) Joshua D. Grill et al.   JOURNAL OF ALZHEIMERS DISEASE

MRI-Based Screening of Preclinical Alzheimer’s Disease for Prevention Clinical Trials

(2018) Adrià Casamitjana et al.   JOURNAL OF ALZHEIMERS DISEASE

High performance plasma amyloid-β biomarkers for Alzheimer’s disease

(2018) Akinori Nakamura et al.   NATURE

Amyloid-β — a reflection of risk or a preclinical marker?

(2018) Clifford R. Jack et al.   Nature Reviews Neurology

Amyloid pathology in the progression to mild cognitive impairment

(2018) Philip S. Insel et al.   NEUROBIOLOGY OF AGING

Dissociable influences ofAPOEε4 and polygenic risk of AD dementia on amyloid and cognition

(2018) Tian Ge et al.   NEUROLOGY

Prevalence and Outcomes of Amyloid Positivity Among Persons Without Dementia in a Longitudinal, Population-Based Setting

(2018) Rosebud O. Roberts et al.   JAMA Neurology

Amyloid β Deposition and Suspected Non-Alzheimer Pathophysiology and Cognitive Decline Patterns for 12 Years in Oldest Old Participants Without Dementia

(2018) Yujing Zhao et al.   JAMA Neurology

Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia

(2018) Willemijn J. Jansen et al.   JAMA Psychiatry

Plasma amyloid as pre-screener for the earliest Alzheimer's pathological changes

(2018) Inge M.W. Verberk et al.   ANNALS OF NEUROLOGY

Identifying Cost-Effective Predictive Rules of Amyloid-β Level by Integrating Neuropsychological Tests and Plasma-Based Markers

(2018) Mona Haghighi et al.   JOURNAL OF ALZHEIMERS DISEASE

Social Event Memory Test (SEMT): A Video-based Memory Test for Predicting Amyloid Positivity for Alzheimer’s Disease

(2018) Ko Woon Kim et al.   Scientific Reports

MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study

(2018) Mara ten Kate et al.   Alzheimers Research & Therapy

Accurate risk estimation of β-amyloid positivity to identify prodromal Alzheimer's disease: Cross-validation study of practical algorithms

(2018) Sebastian Palmqvist et al.   Alzheimers & Dementia

Predicting Progression to Mild Cognitive Impairment

(2018) Ronald C. Petersen et al.   ANNALS OF NEUROLOGY

The combination of apolipoprotein E4, age and Alzheimer's Disease Assessment Scale - Cognitive Subscale improves the prediction of amyloid positron emission tomography status in clinically diagnosed mild cognitive impairment

(2018) M. Ba et al.   EUROPEAN JOURNAL OF NEUROLOGY

A Nomogram for Predicting Amyloid PET Positivity in Amnestic Mild Cognitive Impairment

(2018) Si Eun Kim et al.   JOURNAL OF ALZHEIMERS DISEASE

Regional amyloid accumulation and cognitive decline in initially amyloid-negative adults

(2018) Michelle E. Farrell et al.   NEUROLOGY

Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundació ACE Healthy Brain Initiative (FACEHBI)

(2018) Itziar de Rojas et al.   Alzheimers Research & Therapy

Prediction of Cerebral Amyloid With Common Information Obtained From Memory Clinic Practice

(2018) Jun Ho Lee et al.   Frontiers in Aging Neuroscience

Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [18F]-Flutemetamol PET Scan Result

(2018) Sarah Westwood et al.   Frontiers in Aging Neuroscience

Polygenic hazard score, amyloid deposition and Alzheimer’s neurodegeneration

(2018) Chin Hong Tan et al.   BRAIN

Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons

(2017) Michael C. Donohue et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Plasma Proteomic Profiles of Cerebrospinal Fluid-Defined Alzheimer’s Disease Pathology in Older Adults

(2017) Loïc Dayon et al.   JOURNAL OF ALZHEIMERS DISEASE

Elevated plasma ferritin in elderly individuals with high neocortical amyloid-β load

(2017) K Goozee et al.   MOLECULAR PSYCHIATRY

Spitting images: remaking saliva as a promissory substance

(2017) Mette Kragh-Furbo et al.   NEW GENETICS AND SOCIETY

A blood-based biomarker panel indicates IL-10 and IL-12/23p40 are jointly associated as predictors of β-amyloid load in an AD cohort

(2017) Steve Pedrini et al.   Scientific Reports

Amyloid status imputed from a multimodal classifier including structural MRI distinguishes progressors from nonprogressors in a mild Alzheimer's disease clinical trial cohort

(2016) Duygu Tosun et al.   Alzheimers & Dementia

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria

(2016) Bruno Dubois et al.   Alzheimers & Dementia

Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography

(2016) Sebastian Palmqvist et al.   BRAIN

Genetic Risk as a Marker of Amyloid-β and Tau Burden in Cerebrospinal Fluid

(2016) Nicola Voyle et al.   JOURNAL OF ALZHEIMERS DISEASE

Computerized Cognitive Tests Are Associated with Biomarkers of Alzheimer’s Disease in Cognitively Normal Individuals 10 Years Prior

(2016) Anja Soldan et al.   JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY

Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study

(2016) Samantha C Burnham et al.   LANCET NEUROLOGY

Predicting Alzheimer disease from a blood-based biomarker profile

(2016) Samantha C. Burnham et al.   NEUROLOGY

Accelerating rates of cognitive decline and imaging markers associated with β-amyloid pathology

(2016) Philip S. Insel et al.   NEUROLOGY

Association of Elevated Amyloid Levels With Cognition and Biomarkers in Cognitively Normal People From the Community

(2016) Ronald C. Petersen et al.   JAMA Neurology

Blood metabolite markers of neocortical amyloid-β burden: discovery and enrichment using candidate proteins

(2016) N Voyle et al.   Translational Psychiatry

The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET

(2015) William E. Klunk et al.   Alzheimers & Dementia

Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research

(2015) Sid E. O'Bryant et al.   Alzheimers & Dementia

Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures

(2015) L. G. Apostolova et al.   NEUROLOGY

Amyloid PET imaging in Alzheimer’s disease: a comparison of three radiotracers

(2014) S. M. Landau et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Novel plasma biomarker surrogating cerebral amyloid deposition

(2014) Naoki KANEKO et al.   PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES

Multimodal MRI-based imputation of the Aβ+ in early mild cognitive impairment

(2014) Duygu Tosun et al.   Annals of Clinical and Translational Neurology

QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies

(2013) Penny F. Whiting   ANNALS OF INTERNAL MEDICINE

A blood-based predictor for neocortical Aβ burden in Alzheimer’s disease: results from the AIBL study

(2013) S C Burnham et al.   MOLECULAR PSYCHIATRY

Indicators of amyloid burden in a population-based study of cognitively normal elderly

(2012) M. M. Mielke et al.   NEUROLOGY

Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease

(2012) D. S. Knopman et al.   NEUROLOGY

Plasma Based Markers of [11C] PiB-PET Brain Amyloid Burden

(2012) Steven John Kiddle et al.   PLoS One

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

(2009) Leslie M. Shaw et al.   ANNALS OF NEUROLOGY

Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain

(2009) Tero Tapiola et al.   ARCHIVES OF NEUROLOGY

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Clinical severity of Alzheimer's disease is associated with PIB uptake in PET

(2008) Timo Grimmer et al.   NEUROBIOLOGY OF AGING